---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058141"
form_type: "8-K"
ticker: "BRNS"
cik: "0001828185"
company_name: "Barinthus Biotherapeutics plc."
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T15:59:28.865318+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Barinthus Biotherapeutics shareholders approve all proposals at 2025 AGM

## Summary
- Resolutions to re-elect directors Pierre A. Morgon and Joseph C. Scheeren passed with ~98.9% of votes cast.
- PricewaterhouseCoopers LLP re-appointed as U.K. statutory auditors and ratified as independent auditor for FY2025.
- Shareholders approved director remuneration policy and advisory compensation report for FY2024.
- No dividend recommended for FY2024; statutory accounts received and noted.
- Quorum achieved with 26,993,016 ordinary shares present or represented (66.9% of entitled shares).

## SEC filing metadata
- accession: 0001104659-25-058141
- form_type: 8-K
- ticker: BRNS
- cik: 0001828185
- company_name: Barinthus Biotherapeutics plc.
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/0001104659-25-058141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/tm2517545d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058141
- JSON: https://secwatch.observer/filing/0001104659-25-058141.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.